Inferior Vena Cava Filter Placement during Pregnancy: An Adjuvant Option When Medical Therapy Fails
Author(s) -
Sara Valadares,
Fátima Serrano,
Rita Pinheiro Torres,
Augusta Borges
Publication year - 2013
Publication title -
case reports in obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 2090-6684
pISSN - 2090-6692
DOI - 10.1155/2013/821635
Subject(s) - medicine , inferior vena cava , pulmonary embolism , pregnancy , low molecular weight heparin , venous thrombosis , inferior vena cava filter , warfarin , gestation , surgery , thrombosis , vaginal delivery , obstetrics , cardiology , genetics , biology , atrial fibrillation
The authors present a case of a 27-year-old multiparous woman, with multiple thrombophilia, whose pregnancy was complicated with deep venous thrombosis requiring placement of a vena cava filter. At 15th week of gestation, following an acute deep venous thrombosis of the right inferior limb, anticoagulant therapy with low-molecular-weight heparin (LMWH) was instituted without improvement in her clinical status. Subsequently, at 18 weeks of pregnancy, LMWH was switched to warfarin. At 30th week of gestation, the maintenance of high thrombotic risk was the premise for placement of an inferior vena cava filter for prophylaxis of pulmonary embolism during childbirth and postpartum. There were no complications and a vaginal delivery was accomplished at 37 weeks of gestation. Venal placement of inferior vena cava filters is an attractive option as prophylaxis for pulmonary embolism during pregnancy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom